Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BASIL T DARRAS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology

NPI
1538191309
CMS profile
296783
Location
BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$42,464.18

106 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
F. Hoffmann-La Roche AG $15,059.85 34
AveXis $11,954.36 50
Sarepta Therapeutics, Inc. $8,788.61 10
Biogen, Inc. $5,664.44 6
Roche Products Limited $830.00 1
VERTEX PHARMACEUTICALS INCORPORATED $166.09 4
Retrophin, Inc. $0.83 1

Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BASIL T DARRAS

NPI 1538191309 · CMS profile ID 296783

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology with Special Qualifications in Child Neurology

BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1538191309?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BASIL T DARRAS, NPI 1538191309, CMS profile ID 296783. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1538191309?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). BASIL T DARRAS, NPI 1538191309, CMS profile ID 296783. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1538191309?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
BASIL T DARRAS, NPI 1538191309, CMS profile ID 296783, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–106 of 106 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1538191309?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

106 matching records · $42,464.18 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 106 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–106 of 106.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
F. Hoffmann-La Roche AG $326.0603/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681073329 CMS
F. Hoffmann-La Roche AG $222.7403/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681073501 CMS
F. Hoffmann-La Roche AG $278.0803/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681075343 CMS
F. Hoffmann-La Roche AG $286.3803/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681075449 CMS
Sarepta Therapeutics, Inc. $800.0003/18/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681675063 CMS
F. Hoffmann-La Roche AG $2,580.0001/24/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681075943 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $42,464.18 106
PY2020 $60,144.67 38
PY2021 $7,696.67 9
PY2022 $47,725.43 52
PY2023 $39,118.39 44
PY2024 $29,611.00 16
PY2025 $25,829.33 23

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $12,254.16 11
PY2025 Principal investigator $1,105,304.26 25
PY2024 Recipient $6,658.85 6
PY2024 Principal investigator $1,310,794.79 25
PY2023 Recipient $5,103.44 8
PY2023 Principal investigator $819,329.30 28
PY2022 Recipient $845.12 1
PY2022 Principal investigator $1,683,792.83 37
PY2021 Recipient $4,968.04 12
PY2021 Principal investigator $633,334.72 28
PY2020 Recipient $22,007.37 35
PY2020 Principal investigator $1,216,117.83 39
PY2019 Principal investigator $1,420,313.73 39

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

36 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PTC Therapeutics, Inc. $2,000.00 12/16/2025 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249092611
Principal investigator 1 Biogen, Inc. $50,800.00 12/01/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
An Open Label, Single Cohort Study to Assess the Pharmacokinetic Profile of Nusinersen (BIIB058) Administered Via the ThecaFlex DRx System (PIERRE-PK) No dispute reported 06/30/2026 1236947112
Principal investigator 1 Novartis Pharmaceuticals Corporation $30.00 12/01/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 IT or OAV101 IV in Clinical Trials No dispute reported 06/30/2026 1190297341
Recipient F. Hoffmann-La Roche AG $504.44 10/21/2025 Covered Recipient Physician Safety update: Risdiplam clinical trial program for spinal muscular atrophy (SMA) No dispute reported 06/30/2026 1211534819
Recipient F. Hoffmann-La Roche AG $501.16 10/10/2025 Covered Recipient Physician RO7034067 IN ADULT AND PEDIATRIC PATIENTS WITH SPINAL MUSCULAR ATROPHY No dispute reported 06/30/2026 1211534816
Principal investigator 1 Novartis Pharmaceuticals Corporation $12,425.30 10/03/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101 No dispute reported 06/30/2026 1190296493
Principal investigator 1 PTC Therapeutics, Inc. $2,625.00 09/26/2025 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249092599
Principal investigator 1 PTC Therapeutics, Inc. $236.25 09/26/2025 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249092601
Principal investigator 1 Genentech, Inc. $64,005.00 09/10/2025 Non-covered Recipient Entity
BOSTON CHILDRENS HOSPITAL RESEARCH FINANCE
GYM329 RO7204239 IN COMBINATION WITH RISDIPLAM RO7034067 IN PATIENTS WITH SPINAL MUSCULAR ATROPHY No dispute reported 06/30/2026 1211581965
Principal investigator 1 PTC Therapeutics, Inc. $956.25 08/29/2025 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249092595
Recipient F. Hoffmann-La Roche AG $582.97 07/21/2025 Covered Recipient Physician Baseline demographics and clinical characteristics of risdiplam-treated individuals with SMA from the Pediatric Neuromuscular Clinical Research (PNCR) registry No dispute reported 06/30/2026 1211534813
Recipient F. Hoffmann-La Roche AG $459.04 07/18/2025 Covered Recipient Physician FIREFISH Parts 1 and 2: 5-year efficacy and safety of risdiplam in Type 1 SMA No dispute reported 06/30/2026 1211534804
Recipient F. Hoffmann-La Roche AG $209.41 07/18/2025 Covered Recipient Physician Real-world risdiplam effectiveness in adults with SMA from the Pediatric Neuromuscular Clinical Research (PNCR) registry No dispute reported 06/30/2026 1211534809
Principal investigator 1 PTC Therapeutics, Inc. $3,750.00 06/30/2025 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249092589
Principal investigator 1 PTC Therapeutics, Inc. $866.25 06/30/2025 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249092591
Recipient F. Hoffmann-La Roche AG $1,097.92 06/25/2025 Covered Recipient Physician Baseline demographics and clinical characteristics of risdiplam-treated individuals with SMA from the Pediatric Neuromuscular Clinical Research (PNCR) registry No dispute reported 06/30/2026 1211534824
Recipient F. Hoffmann-La Roche AG $259.30 06/06/2025 Covered Recipient Physician Real-world risdiplam effectiveness in adults with SMA from the Pediatric Neuromuscular Clinical Research (PNCR) registry No dispute reported 06/30/2026 1211534828
Principal investigator 1 Genentech, Inc. $49,812.00 05/27/2025 Non-covered Recipient Entity
BOSTON CHILDRENS HOSPITAL RESEARCH FINANCE
GYM329 RO7204239 IN COMBINATION WITH RISDIPLAM RO7034067 IN PATIENTS WITH SPINAL MUSCULAR ATROPHY No dispute reported 06/30/2026 1211581962
Principal investigator 1 Novartis Pharmaceuticals Corporation $76,413.90 05/23/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101 No dispute reported 06/30/2026 1190294912
Principal investigator 1 PTC Therapeutics, Inc. $236.25 04/30/2025 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249092583
Recipient F. Hoffmann-La Roche AG $768.70 03/31/2025 Covered Recipient Physician Real-world risdiplam effectiveness in adults with spinal muscular atrophy (SMA) from the Pediatric Neuromuscular Clinical Research (PNCR) registry No dispute reported 06/30/2026 1211534832
Principal investigator 1 Sarepta Therapeutics, Inc. $2,137.50 03/19/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
4045-301 No dispute reported 06/30/2026 1223610453
Recipient Novartis Pharma AG $2,825.00 03/18/2025 Covered Recipient Physician COAV101B12301 No dispute reported 06/30/2026 1248109103
Principal investigator 1 Sarepta Therapeutics, Inc. $2,500.00 03/12/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
4045-301 No dispute reported 06/30/2026 1223610455
Principal investigator 1 Sarepta Therapeutics, Inc. $750.00 03/12/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
4045-301 No dispute reported 06/30/2026 1223610457
Principal investigator 1 PTC Therapeutics, Inc. $866.25 02/27/2025 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249092579
Principal investigator 1 Genentech, Inc. $314,033.00 02/14/2025 Non-covered Recipient Entity
BOSTON CHILDRENS HOSPITAL RESEARCH FINANCE
GYM329 RO7204239 IN COMBINATION WITH RISDIPLAM RO7034067 IN PATIENTS WITH SPINAL MUSCULAR ATROPHY No dispute reported 06/30/2026 1211581958
Principal investigator 1 Sarepta Therapeutics, Inc. $34,336.21 02/14/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
4045-301 No dispute reported 06/30/2026 1223610451
Recipient Novartis Pharmaceuticals Corporation $1,322.08 01/31/2025 Covered Recipient Physician Research Publication/Writing Support No dispute reported 06/30/2026 1190293431
Recipient Novartis Pharmaceuticals Corporation $3,724.14 01/30/2025 Covered Recipient Physician STRENGTH No dispute reported 06/30/2026 1190293427
Principal investigator 1 PTC Therapeutics, Inc. $360.00 01/30/2025 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
AN OPEN-LABEL, SAFETY STUDY FOR ATALUREN (PTC124) PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY No dispute reported 06/30/2026 1249092575
Principal investigator 1 Biogen, Inc. $33,248.82 01/23/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
An Open-Label Extension Study for Patients With Spinal Muscular AtrophyWho Previously Participated in Investigational Studies of ISIS 396443 No dispute reported 06/30/2026 1236947250
Principal investigator 1 Biogen, Inc. $56,468.00 01/10/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy No dispute reported 06/30/2026 1236947388
Principal investigator 1 Biogen, Inc. $161,224.00 01/08/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
A Phase 3b Study to Evaluate Higher Dose Nusinersen (BIIB058) in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam No dispute reported 06/30/2026 1236947564
Principal investigator 1 Biogen, Inc. $234,894.28 01/06/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study with Nusinersen. No dispute reported 06/30/2026 1236948082
Principal investigator 1 Novartis Pharmaceuticals Corporation $330.00 01/01/2025 Covered Recipient Teaching Hospital
Childrens Hospital Corporation
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 IT or OAV101 IV in Clinical Trials No dispute reported 06/30/2026 1190294918